These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15104560)

  • 1. Growth hormone receptor expression and function in pituitary adenomas.
    Clausen LR; Kristiansen MT; Rasmussen LM; Billestrup N; Blaabjerg O; Ledet T; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 May; 60(5):576-83. PubMed ID: 15104560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
    Barbieri F; Bajetto A; Stumm R; Pattarozzi A; Porcile C; Zona G; Dorcaratto A; Ravetti JL; Minuto F; Spaziante R; Schettini G; Ferone D; Florio T
    Clin Cancer Res; 2008 Aug; 14(16):5022-32. PubMed ID: 18698020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of growth hormone receptors in human prostate cancer cell lines.
    Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
    Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
    Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
    Filby AL; Tyler CR
    Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
    Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
    Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate development.
    Cruickshank J; Grossman DI; Peng RK; Famula TR; Oberbauer AM
    J Endocrinol; 2005 Mar; 184(3):543-53. PubMed ID: 15749813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
    Emery MN; Leontiou C; Bonner SE; Merulli C; Nanzer AM; Musat M; Galloway M; Powell M; Nikookam K; Korbonits M; Grossman AB
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):389-95. PubMed ID: 16918962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
    Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
    Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I (IGF-I) and its receptor (IGF-1R) in the rat anterior pituitary.
    Eppler E; Jevdjovic T; Maake C; Reinecke M
    Eur J Neurosci; 2007 Jan; 25(1):191-200. PubMed ID: 17241280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.